Patents by Inventor Noriko ISHIGURO

Noriko ISHIGURO has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11667630
    Abstract: A novel compound represented by the following general formula (1), or a salt thereof, which has a superior EP4 receptor agonist activity, and a medicament containing the compound or a salt thereof as an active ingredient, which can be used for promotion of osteogenesis, therapeutic treatment and/or promotion of healing of fracture and the like.
    Type: Grant
    Filed: March 4, 2021
    Date of Patent: June 6, 2023
    Assignee: ASAHI KASEI PHARMA CORPORATION
    Inventors: Daisuke Shikanai, Noriko Ishiguro, Osamu Omori
  • Publication number: 20210188837
    Abstract: A novel compound represented by the following general formula (1), or a salt thereof, which has a superior EP4 receptor agonist activity, and a medicament containing the compound or a salt thereof as an active ingredient, which can be used for promotion of osteogenesis, therapeutic treatment and/or promotion of healing of fracture and the like.
    Type: Application
    Filed: March 4, 2021
    Publication date: June 24, 2021
    Applicant: Asahi Kasei Pharma Corporation
    Inventors: Daisuke SHIKANAI, Noriko ISHIGURO, Osamu OMORI
  • Patent number: 10988468
    Abstract: A novel compound represented by the following general formula (1), or a salt thereof, which has a superior EP4 receptor agonist activity, and a medicament containing the compound or a salt thereof as an active ingredient, which can be used for promotion of osteogenesis, therapeutic treatment and/or promotion of healing of fracture and the like.
    Type: Grant
    Filed: December 25, 2018
    Date of Patent: April 27, 2021
    Assignee: ASAHI KASEI PHARMA CORPORATION
    Inventors: Daisuke Shikanai, Noriko Ishiguro
  • Publication number: 20200347046
    Abstract: A novel compound represented by the following general formula (1), or a salt thereof, which has a superior EP4 receptor agonist activity, and a medicament containing the compound or a salt thereof as an active ingredient, which can be used for promotion of osteogenesis, therapeutic treatment and/or promotion of healing of fracture and the like.
    Type: Application
    Filed: December 25, 2018
    Publication date: November 5, 2020
    Applicant: Asahi Kasei Pharma Corporation
    Inventors: Daisuke SHIKANAI, Noriko ISHIGURO, Osamu OMORI